medicallessons.net
Crizotinib, An Experimental Drug for Some Lung Cancers and Other Tumors With Alk Mutations
Why am I blogging about this drug, a pill, that works imperfectly in perhaps most of 5% of non-small-cell lung cancer patients and, maybe, in some other rare tumors? Because this is the future of oncology and, ultimately I think, will provide cost-effective medicine that's based in evidence and science. The key is that the…